Market revenue in 2023 | USD 90,373.6 million |
Market revenue in 2030 | USD 206,813.8 million |
Growth rate | 12.6% (CAGR from 2023 to 2030) |
Largest segment | Health |
Fastest growing segment | Bioinformatics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Health, Food & Agriculture, Natural reseources & Environment, Industrial Processing, Bioinformatics, Others Applications |
Key market players worldwide | AstraZeneca PLC, Gilead Sciences Inc, Bristol-Myers Squibb Co, Sanofi SA, Biogen Inc, Abbott Laboratories, Pfizer Inc, Amgen Inc, Novo Nordisk A/S ADR, Merck KGaA, Johnson & Johnson, Novartis AG ADR, Roche Holding AG, Lonza Group Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology market will help companies and investors design strategic landscapes.
Health was the largest segment with a revenue share of 44.06% in 2023. Horizon Databook has segmented the Canada biotechnology market based on health, food & agriculture, natural reseources & environment, industrial processing, bioinformatics, others applications covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is recognized for its advanced healthcare and life sciences solutions. The country is home to highly skilled and experienced life sciences professionals. It hosts an innovative environment for the life sciences industry, with broad research networks, abundant partnership opportunities, first-rate academic institutions, and lower costs.
The biotechnology market in Canada is expected to register significant growth throughout he forecast period owing to the ongoing advancements by institutions such as the Ontario University for development of molecular and companion diagnostics using applications of next-generation sequencing.
Furthermore, technological advancements in applications such as noninvasive prenatal testing and large-scale population sequencing projects are also expected to drive demand through to 2030. The capital raised by Canadian biotechnology companies has increased significantly in recent years.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada biotechnology market , including forecasts for subscribers. This country databook contains high-level insights into Canada biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account